← Leaderboards
Tobey James Betthauser
University Of Wisconsin-Madison
$2,969,775
Attributed
$3,643,211
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$3,643,211 · 2
By mechanism
R01$2,296,338 · 1
RF1$1,346,873 · 1
Top collaborators
- Matthew Zammit1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Bradley T Christian$32,543,306
- Sigan L Hartley$10,337,741
- Anita Bhattacharyya$7,278,509
- Desmond Oathes$8,268,852
- Michal Engelman$15,819,943
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposPositron-Emission TomographyClinical TrialsGeneticInsightPathologicCohortCognitionAge Of OnsetDisease ProgressionImpaired CognitionAmyloid Beta-ProteinMeasurableNerve DegenerationImageAccountingAlzheimerâS Disease BiomarkerClinical Trials DesignAlzheimer Disease PreventionBiological MarkersAmyloidDementiaAccelerationPre-Clinical
Grant awards (4)
Establishing an Alzheimerâs disease biomarker clock in Down syndrome using positron emission tomography and plasma analytes$1,346,873
RF1 · FY2025 · AG
Multi-cohort study of factors that influence Alzheimer's disease biomarker and dementia timing$755,322
R01 · FY2025 · AG · contact PI
Multi-cohort study of factors that influence Alzheimer's disease biomarker and dementia timing$770,594
R01 · FY2024 · AG · contact PI
Multi-cohort study of factors that influence Alzheimer's disease biomarker and dementia timing$770,422
R01 · FY2023 · AG · contact PI